Clinical Trial Update: Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

View source ↗

Summary

A BioNTech-sponsored epidemiological study monitoring circulating tumor DNA in participants with resected stage II (high risk) or stage III colorectal cancer be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: BioNTech SE | Conditions: Colorectal Cancer Stage II, Colorectal Cancer Stage III | Status: ACTIVE_NOT_RECRUITING